TY - JOUR
T1 - Clinical practice guidelines for the management of patients with endometrial cancer in france recommendations of the institut national du cancer and the société française d'oncologie gynécologique
AU - Querleu, Denis
AU - Planchamp, François
AU - Narducci, Fabrice
AU - Morice, Philippe
AU - Joly, Florence
AU - Genestie, Catherine
AU - Haie-Meder, Christine
AU - Thomas, Laurence
AU - Quénel-Tueux, Nathalie
AU - Daraï, Emile
AU - Dorangeon, Pierre Hervé
AU - Marret, Henri
AU - Taïeb, Sophie
AU - Mazeau-Woynar, Valérie
PY - 2011/7/1
Y1 - 2011/7/1
N2 - Introduction: Endometrial cancer is the most common gynecological malignancy in France, with more than 6500 new cases in 2010. The French National Cancer Institute has been leading a clinical practice guidelines (CPG) project since 2008. This project involves the development and updating of evidence-based CPG in oncology. Objective: To develop CPG for diagnosis, treatment, and follow-up for patients with endometrial cancer. Methods: The guideline development process is based on systematic literature review and critical appraisal by experts, with feedback from specialists in cancer care delivery. The recommendations are thus based on the best available evidence and expert agreement. Results: Main recommendations include a routine pelvic magnetic resonance imaging in association with magnetic resonance imaging exploration of the para-aortic lymph nodes for locoregional staging, surgical treatment based on total hysterectomy with bilateral salpingo-oophorectomy with or without lymphadenectomy, and clinical examination for the follow-up. The initial laparoscopic surgical approach is recommended for stage I tumors. Lymphadenectomy and postoperative external radiotherapy are recommended for patients with high risk of recurrence but are restricted for patients with low or intermediate risk. If brachytherapy is indicated, it should be given at a high-dose rate rather than a low-dose rate. Routine imaging, biologic tests, and vaginal smears are not indicated for follow-up.
AB - Introduction: Endometrial cancer is the most common gynecological malignancy in France, with more than 6500 new cases in 2010. The French National Cancer Institute has been leading a clinical practice guidelines (CPG) project since 2008. This project involves the development and updating of evidence-based CPG in oncology. Objective: To develop CPG for diagnosis, treatment, and follow-up for patients with endometrial cancer. Methods: The guideline development process is based on systematic literature review and critical appraisal by experts, with feedback from specialists in cancer care delivery. The recommendations are thus based on the best available evidence and expert agreement. Results: Main recommendations include a routine pelvic magnetic resonance imaging in association with magnetic resonance imaging exploration of the para-aortic lymph nodes for locoregional staging, surgical treatment based on total hysterectomy with bilateral salpingo-oophorectomy with or without lymphadenectomy, and clinical examination for the follow-up. The initial laparoscopic surgical approach is recommended for stage I tumors. Lymphadenectomy and postoperative external radiotherapy are recommended for patients with high risk of recurrence but are restricted for patients with low or intermediate risk. If brachytherapy is indicated, it should be given at a high-dose rate rather than a low-dose rate. Routine imaging, biologic tests, and vaginal smears are not indicated for follow-up.
KW - Clinical practice guidelines
KW - Diagnosis
KW - Endometrial cancer
KW - Follow-up
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=80955129050&partnerID=8YFLogxK
U2 - 10.1097/IGC.0b013e31821bd473
DO - 10.1097/IGC.0b013e31821bd473
M3 - Article
C2 - 21697683
AN - SCOPUS:80955129050
SN - 1048-891X
VL - 21
SP - 945
EP - 950
JO - International Journal of Gynecological Cancer
JF - International Journal of Gynecological Cancer
IS - 5
ER -